Tevogen Bio expands collaboration with Microsoft to develop PredicTcell technology for T cell targeting

From GlobeNewswire: 2025-01-24 17:34:26

Tevogen Bio Holdings Inc. has expanded its collaboration with Microsoft to build its PredicTcell technology for T cell targeting, accelerating the identification of new targets and decoding HLA-T cell interactions. The company is also investigating potential treatments for Human Papillomavirus (HPV) using AI and machine learning. Tevogen Bio’s ExacTcell™ technology aims to develop personalized immunotherapies for infectious diseases, cancers, and neurological disorders. Tevogen Bio is committed to revolutionizing immunotherapy and bringing precise treatments to patients at an accelerated pace through advanced science and innovative business models.



Read more at GlobeNewswire: Tevogen Bio Broadens Relationship with Microsoft to Deepen